NASDAQ:IMTX

Immatics Biotechnologies Gmbh Stock Forecast

etoro logo Buy IMTX
*Your capital is at risk
$10.21
+0.165 (+1.64%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of IMTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IMTX to Watchlist?
Some Reasons Why To Add IMTX:
  • High gross margin of 100.0%
  • +77.5% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 5.49)
PDF

immatics biotechnologies GmbH stock upgraded to Hold/Accumulate
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jun 03, 2026

The immatics biotechnologies GmbH stock price gained 1.64% on the last trading day (Wednesday, 3rd Jun 2026), rising from $10.04 to $10.21. During the last trading day the stock fluctuated 5.15% from a day low at $9.71 to a day high of $10.21. The price has risen in 6 of the last 10 days but is still down by -4.63% for this period. Volume fell on the last day by -2 million shares and in total, 537 thousand shares were bought and sold for approximately $5.48 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.07 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 17.55% during the next 3 months and, with a 90% probability hold a price between $11.83 and $13.89 at the end of this 3-month period.

IMTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 1.64%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The immatics biotechnologies GmbH stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.99 and $11.12. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for immatics biotechnologies GmbH stock

immatics biotechnologies GmbH finds support from accumulated volume at $10.04 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.500 between high and low, or 5.15%. For the last week, the stock has had daily average volatility of 6.04%.

Our recommended stop-loss: $9.70 (-5.00%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (IMTX) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect immatics biotechnologies GmbH to open at $10.04, and during the day (based on 14 day Average True Range), to move between $9.90 and $10.51, which gives a possible trading interval of +/-$0.602 (+/-6.08%) up or down from last closing price. If immatics biotechnologies GmbH takes out the full calculated possible swing range there will be an estimated 6.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.04 (1.62%) than the resistance at $10.79 (5.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is immatics biotechnologies GmbH stock A Buy?

immatics biotechnologies GmbH holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.328 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $10.04 ( 1.60%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IMTX Performance

Trading levels for IMTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 10.54 3.30%
R2 10.35 1.43%
R1 10.23 0.271%
Price 10.21
S1 9.85 -3.47%
S2 9.73 -4.63%
S3 9.54 -6.50%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.51 12.79%
R2 11.14 9.16%
R1 10.79 5.73%
Price 10.21
S1 10.04 -1.62%
S2 10.03 -1.71%
S3 9.20 -9.85%

FAQ

What is the symbol for immatics biotechnologies GmbH Stock and on which exchange is it traded?
The symbol for immatics biotechnologies GmbH is IMTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell immatics biotechnologies GmbH Stock?
immatics biotechnologies GmbH holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy immatics biotechnologies GmbH Stock?
immatics biotechnologies GmbH Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy immatics biotechnologies GmbH Stock.

What's the current price of immatics biotechnologies GmbH Stock?
As of the end of day on the Jun 03, 2026, the price of an immatics biotechnologies GmbH (IMTX) share was $10.21.

What is the 52-week high and low for immatics biotechnologies GmbH Stock?
The 52-week high for immatics biotechnologies GmbH Stock is $12.38 and the 52-week low is $5.05.

What is the market capitalization of immatics biotechnologies GmbH Stock?
As of the Jun 03, 2026, the market capitalization of immatics biotechnologies GmbH is 1.346B.

When is the next earnings date for immatics biotechnologies GmbH?
The upcoming earnings date for immatics biotechnologies GmbH is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT IMMATICS BIOTECHNOLOGIES GMBH
immatics biotechnologies GmbH
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE